Kidney failure has emerged as one of the most prominent causes of death in recent times. As per an article published in ScienceDirect in April 2022, CKD is a progressive disease affecting over 10% of the population worldwide, representing more than 800 million individuals. As people age, they become more susceptible to renal illnesses due to age-related conditions such as hypertension and diabetes. Dialysis is a life-saving treatment that helps eliminate excess fluid and waste products from the blood when the kidneys can’t function properly. Dialysis equipment is required to manage patients with impaired kidney function. With the increase in the aging population worldwide and the burgeoning number of patients diagnosed with CKD or end-stage renal disease (ESRD), the demand for dialysis equipment such as hemodialysis machines, dialyzers, and dialysis concentrate is expected to rise significantly. Thus, the increasing prevalence of CKD, driven by determinants such as hypertension, obesity, diabetes, and an aging population, bolsters the kidney dialysis equipment market size 2022–2030.
The geographic scope of the kidney dialysis equipment market report entails North America (US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). Asia Pacific is expected to register the fastest CAGR in the kidney dialysis equipment market during the forecast period.
North America held the largest kidney dialysis equipment market share in 2022. The US held the largest share of the market in this region in 2022, followed by Canada, owing to the increasing prevalence of CKD among people in the region. According to the National Health Institute of Diabetes and Digestive and Kidney Diseases, in 2021, over 37 million adults in the US were affected by CKD. ~808,000 Americans were living with ESKD in 2020, out of which 69% were on dialysis and 31% underwent a kidney transplant. Other factors propelling the kidney dialysis equipment market growth in North America include the introduction of advanced equipment in healthcare, a rising number of hospitals, increasing healthcare expenditures, and the implementation of strategic policies by governments.
Kidney Dialysis Equipment Market: Segmental Overview
The kidney dialysis equipment market is segmented on the basis of product, application, and end user. By product, the market is segmented into hemodialysis and peritoneal dialysis equipment. By end user, the market is segmented into in-center dialysis settings and home care settings.
The hemodialysis equipment segment held a larger kidney dialysis equipment market share in 2022. It is projected to register a higher CAGR in the market during 2022–2030. Hemodialysis is a medical treatment to filter waste and excess fluid from the blood, which is indicated when the kidneys cannot perform their functions. The procedure helps control blood pressure and maintain the balance of essential blood minerals, including sodium, potassium, and calcium. The hemodialysis equipment filters blood through a dialyzer that acts as an artificial kidney with inbuilt safety check features, ensuring the safety and effectiveness of dialysis.
Kidney Dialysis Equipment Market: Competitive Landscape and Key Developments
Baxter; B. Braun Medical Inc.; BD; Cantel Medical; DaVita Inc.; Fresenius Medical Care; Medtronic; Nikkiso Co., Ltd.; Asahi Kasei Corporation; and Terumo Corporation are among the prominent companies profiled in kidney dialysis equipment market report. In addition, several other players have been studied and analyzed during the study to get a holistic view of the market and its ecosystem. The players adopt product innovation strategies to meet evolving customer demands, maintaining their brand image.
A few recent developments by players operating in the kidney dialysis equipment market are mentioned below:
In October 2023, Quanta Dialysis Technologies presented real-world evidence from its Home Run study using its Quanta Dialysis System at the American Society of Nephrology (ASN) Kidney Week 2023, held from November 2 to 5 in Philadelphia, Pennsylvania.
January 2022, Nextkidney BV acquired Dialyss Pte Ltd. The acquisition of this Singapore-based company significantly allowed Nextkidney to boost the development and commercialization processes of its portable hemodialysis device—Neokidney. It is a small, user-friendly, cost-effective home hemodialysis device capable of handling 4 liters of dialysate per session. The device is independent of water supply and drain, rendering it available to patients anytime and anywhere.
In March 2021, Baxter International Inc. received clearance from the US Food and Drug Administration (FDA) for its Artificial Kidney 98 (AK 98) dialysis machine, a next-generation kidney dialysis equipment. It is a portable and easy-to-use system to administer hemodialysis treatments.
In December 2020, Medtronic plc launched the Carpediem Cardio-Renal Dialysis Machine for pediatric emergencies. First Carpediem systems were successfully installed in the US at Cincinnati Children’s Hospital Medical Center. It is indicated for acute kidney injury or patients with fluid overload requiring hemodialysis or hemofiltration therapy. The systems are also deployed to provide continuous renal replacement therapy (CRRT) to patients weighing in the range of 2.5–10 kg.